Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Efficacy of VLY-686 in Relieving Symptoms of Gastroparesis

ClinicalTrials.gov ID: NCT02970968

Public ClinicalTrials.gov record NCT02970968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in the United States. One hundred fifty (150) subjects diagnosed with gastroparesis, who satisfy the selection criteria for the study, will be randomized to one of two treatment groups, active or placebo.

Study identification

NCT ID
NCT02970968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
152 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2016
Primary completion
Oct 31, 2018
Completion
Nov 30, 2018
Last update posted
Aug 5, 2024

2016 – 2018

United States locations

U.S. sites
38
U.S. states
24
U.S. cities
37
Facility City State ZIP Site status
Vanda Investigational Site Dothan Alabama 36305
Vanda Investigational Site Huntsville Alabama 35801
Vanda Investigational Site Tucson Arizona 85712
Vanda Investigational Site Little Rock Arkansas 72211
Vanda Investigational Site Chula Vista California 91910
Vanda Investigational Site Los Angeles California 90095
Vanda Investigational Site Palo Alto California 94305
Vanda Investigational Site San Francisco California 94115
Vanda Investigational Site Jacksonville Florida 32256
Vanda Investigational Site Largo Florida 33777
Vanda Investigational Site Miami Florida 33134
Vanda Investigational Site Athens Georgia 30607
Vanda Investigational Site Elgin Illinois 60123
Vanda Investigational Site Indianapolis Indiana 46202
Vanda Investigational Site Louisville Kentucky 40202
Vanda Investigational Site Marrero Louisiana 70072
Vanda Investigational Site Chevy Chase Maryland 20815
Vanda Investigational Site Boston Massachusetts 02114
Vanda Investigational Site Boston Massachusetts 02215
Vanda Investigational Site Wyoming Michigan 49519
Vanda Investigational Site Minneapolis Minnesota 55114
Vanda Investigational Site Pascagoula Mississippi 39564
Vanda Investigational Site St Louis Missouri 63104
Vanda Investigational Site Great Neck New York 11023
Vanda Investigational Site New York New York 10028
Vanda Investigational Site Raleigh North Carolina 27612
Vanda Investigational Site Salisbury North Carolina 28144
Vanda Investigational Site Huber Heights Ohio 45424
Vanda Investigational Site Mentor Ohio 44060
Vanda Investigational Site Tulsa Oklahoma 74104
Vanda Investigational Site Philadelphia Pennsylvania 19140
Vanda Investigational Site Chattanooga Tennessee 37421
Vanda Investigational Site Jackson Tennessee 38305
Vanda Investigational Site Nashville Tennessee 37211
Vanda Investigational Site El Paso Texas 79905
Vanda Investigational Site Houston Texas 77030
Vanda Investigational Site Richardson Texas 75082
Vanda Investigational Site Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02970968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02970968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →